PDS Biotechnology Corp (PDSB)

PDS Biotechnology Corp (PDSB) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $66.4M; returns 1 day -4.3%, 1 week -1.8%, 1 year +20.7%.

PDS Biotechnology Corporation (PDSB) is a clinical-stage biopharmaceutical company primarily focused on developing novel, multifunctional cancer immunotherapies based on its proprietary Versamune® T-cell activating platform.

Groups PDSB belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Immunotherapy
• Clinical Stage
• Oncology
• Cancer Therapeutics
• Healthcare
• Life Sciences
• Antibody-Drug Conjugates

PDSB financial model: income statement, cash flow and balance sheet